Indolidan is a small-molecule cardiotonic agent originally developed by Eli Lilly & Co. for the treatment of heart failure.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.